Instrument NameAmerican Well Corp Cl AInstrument Symbol(AMWL-N)

Instrument ExchangeNYSE

Amwell delivered a solid fourth quarter and encouraging 2025 outlook.

AMWL earnings call for the period ending December 31, 2023.

AMWL earnings call for the period ending September 30, 2023.

The telehealth platform provider was selected to help upgrade the U.S. Military Health System.

Amazon Clinic could play a key role in the company's next big move.

AMWL earnings call for the period ending June 30, 2023.

DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic

AMWL earnings call for the period ending March 31, 2023.

Amwell ® (NYSE: AMWL), a leader in digital healthcare enablement, today announced financial results for the first quarter ended March 31, 2023.

Amwell ® , (NYSE: AMWL) a leader in digital healthcare enablement, today announced participation in the following investor conferences:

Amwell ® (NYSE: AMWL), a leader in digital health care enablement, today announced it will report its first-quarter 2023 operating results on Wed., May 3, 2023. Following distribution of the earnings release via wire services, the Amwell...

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today a...

Amwell ® (NYSE: AMWL), a leader in digital healthcare enablement, today announced the expansion of its digital clinical programs to include a cardiometabolic program, enabling health plans and clinicians to seamlessly connect members living...

The fallout continued from the company's fourth-quarter and full-year 2022 earnings release.

AMWL earnings call for the period ending December 31, 2022.

Amwell ® (NYSE: AMWL), a leader in digital healthcare enablement, today announced financial results for the fourth quarter and full year ended December 31, 2022.

Amwell ® , (NYSE: AMWL) a leader in digital healthcare enablement, today announced that its CFO, Robert Shepardson, will participate in a fireside chat at the Cowen 43 rd Annual Healthcare Conference on March 7, 2023 at 9:10AM ET.

Amwell ® , (NYSE: AMWL ) a leader in digital healthcare enablement, today announced that it will report fourth quarter, ended December 31, 2022, operating results on Wednesday, February 22, 2023. Following distribution of the earnings release...

These are far from sure things, but there's tremendous upside if they can execute.

AMWL earnings call for the period ending September 30, 2022.

Amwell ® (NYSE: AMWL), a leader in digital healthcare enablement, today announced financial results for the third quarter ended September 30, 2022.

Amwell ® , (NYSE: AMWL) a leader in digital healthcare enablement, today announced the appointment of Robert Webb to the Company’s Board of Directors, effective immediately. Mr. Webb will further strengthen the Amwell Board and market position,...

Amwell ® , (NYSE: AMWL) a leader in digital healthcare enablement, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

Amwell ® , (NYSE: AMWL) a leader in digital healthcare enablement, today announced that it will report third quarter ended September 30, 2022 operating results on Monday November 7, 2022. Following distribution of the earnings release via wire...

Amwell® (NYSE: AMWL), a digital care delivery leader, today announced the appointments of Vaughn Paunovich to the role of Executive Vice President, Enterprise Platforms, and Matthew McAllister to Chief Product Officer. Vaughn will oversee...